Long-term effectiveness and drug survival of golimumab in patients affected by psoriatic arthritis with cutaneous involvement

OBJECTIVES: To determine the effectiveness of golimumab (GLM) in improving joint, periarticular structures and cutaneous manifestations in patients with moderate to severe psoriatic arthritis (PsA) with cutaneous psoriasis in different real-life clinical settings and 48-month drug survival. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Chimenti, Maria Sole, Conigliaro, Paola, Caso, Francesco, Costa, Luisa, Ortolan, Augusta, Triggianese, Paola, Tasso, Marco, Fonti, Giulia Lavinia, Lorenzin, Maria Grazia, Perricone, Roberto, Ramonda, Roberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724144/
https://www.ncbi.nlm.nih.gov/pubmed/34410550
http://dx.doi.org/10.1007/s10067-021-05874-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724144/
https://www.ncbi.nlm.nih.gov/pubmed/34410550
http://dx.doi.org/10.1007/s10067-021-05874-6

Ejemplares similares